A new study found that police drug seizures are associated with increased fatal overdoses in the surrounding geographic area, suggesting that efforts to disrupt drug markets can have unintended effects. The research highlights the need for comprehensive policing strategies that consider all outcomes, including harm reduction approaches.
A statewide pay-for-performance intervention based on Choosing Wisely reduced rates of inappropriate antibiotic prescriptions for acute respiratory tract infections from 43% to 25%. This reduction occurred without measurable harms at safety-net hospitals serving disadvantaged patients.
Researchers have developed a color-changing material that can detect when medications get too warm, with tunable melting points to track temperatures from -94 to +99 degrees Fahrenheit. This innovative system has the potential to reduce electronic waste and improve medical cold supply chains.
Researchers at the University of Tsukuba found an association between evaporated alcohol from incubator disinfectants and alcohol absorption in premature infants. They introduced a new practice to reduce alcohol exposure, which was associated with decreased alcohol levels in infants' blood and air.
Researchers have developed a pharmacological treatment that improves cardiac function in patients with stiff-heart syndrome, a condition caused by amyloid protein deposition. The new drug reduces amyloid protein deposits and shows promise in reversing established disease symptoms.
A recent study published in The Lancet Neurology found that valbenazine significantly reduces chorea symptoms in patients with Huntington’s disease. The Phase III trial showed improvement as early as the second week of treatment, with consistently greater benefits compared to a placebo.
A nationwide analysis of prisoner healthcare incidents in England reveals medication-related harm as a major issue, with staff mistakes being the most common cause. The researchers recommend prioritizing timely access to healthcare services, improving processes to mitigate medication-related harm and increasing remote appointments.
A Cochrane review found that most antidepressants used to manage chronic pain lack sufficient evidence of their effectiveness, with only duloxetine showing reliable pain relief. The review also revealed that harms from many commonly recommended drugs have not been well studied, posing a global public health concern.
A study analyzing 34,000 people found that lowering sclerostin levels may increase the risk of heart attack, stroke, and type 2 diabetes. The research suggests that strategies to minimize potential impact on heart attack risk are needed.
A multicentre registry study found that medicinal cannabis can safely relieve cancer pain while reducing the total number of medications and opioids taken. Products with an equal balance of THC and CBD were particularly effective in reducing pain intensity and symptoms.
A new study found that older drivers who use substances are up to four times more likely to be at fault in a car crash. The research team suggests implementing risk awareness campaigns tailored for older adults and other measures such as improved road visibility, automatic safety features and licensing requirements.
A majority of people over 50 are open to stopping one or more prescription medicines, but many don't discuss it with their health provider first. The poll shows that comprehensive medication reviews and cost considerations play a crucial role in deprescribing conversations.
Research finds diclofenac's high variability in metabolism due to UGT2B17, a little-studied enzyme. The study suggests genetic testing and dose adjustments for specific populations can help minimize side effects.
Experts recommend managing SARS-CoV-2 like other endemic respiratory viruses using Standard and Transmission-based Precautions. They also suggest reconsidering pandemic-era strategies such as asymptomatic testing and contact tracing in the endemic era.
Enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body. The drug targets B7-H3 protein overexpressed on prostate cancer cells, blocking immune system inhibition and triggering tumor cell destruction by activating immune cells.
WVU engineers developed a new electrode cuff called MouseFlex to test electric current treatments, overcoming previous challenges with stability and durability. The device can withstand high electrical stimulation and may benefit patients with conditions like rheumatoid arthritis and drug-resistant epilepsy.
A statewide effort in Michigan resulted in a 56% reduction in opioid prescriptions after six common operations and a 26% drop in persistent opioid use. The achievement surpassed national trends, driven by voluntary prescribing guidelines and surgical team involvement.
A new study found that taking a comprehensive medication history before hospital admission and upon discharge significantly reduces medication discrepancies. The study suggests that hospitals can improve medication safety by focusing on these two key efforts.
Researchers from Kessler Foundation found that transcutaneous spinal stimulation does not interfere with implanted intrathecal baclofen pump delivery systems. However, communication between the pump and its interrogator may be briefly affected due to electromagnetic interference.
Researchers have discovered a novel medication that effectively treats a rare hereditary muscle disease causing complete immobility and death. The treatment has also shown promise in treating severe statin-associated myopathy, with improved symptoms in patients awaiting treatment.
Cases of Candida auris, a highly contagious fungal infection, rose drastically between 2019 and 2021, with an increase in echinocandin-resistant cases. The findings emphasize the need for improved detection and infection control practices to prevent the spread of C auris.
Three real-world studies published in the Journal of Hepatology and JHEP Reports demonstrate that bulevirtide is well-tolerated and safe for treating chronic hepatitis delta. Long-term suppressive therapy with BLV monotherapy has the potential to reduce viral replication and improve liver function in difficult-to-treat patients.
A multicenter study found that patients with cystic fibrosis can safely take a dual combination of CF modulator drugs for four years while maintaining previously achieved clinical improvement. This breakthrough therapy has improved the quality and length of patients' lives, with some even seeing a 15% increase in lung function.
A new study published in the New England Journal of Medicine found that lebrikizumab was effective in treating moderate to severe atopic dermatitis, improving skin clarity and reducing itching. The study involved two phase 3 trials with over 700 participants and showed promising results for the treatment.
Recent review article discusses clinical development in long-acting growth hormone (LAGH) therapy, which mimics natural GH release patterns. LAGH therapies reduce daily injection burden, improving patient compliance and treatment outcomes.
A new study by Weill Cornell Medicine found that the FDA's mandate to limit opioid-acetaminophen combinations resulted in significant reductions in liver injuries. The mandate, implemented in 2014, limited the dosage of acetaminophen in these drugs, leading to a decline in hospitalizations and acute liver failure cases.
The March issues of The American Journal of Psychiatry and Psychiatric Services focus on major depression treatment advances and suicide risk screening for Indigenous populations. Journalists can access the publications by emailing press@psych.org.
Wilate prophylaxis showed an 84% reduction in bleeding episodes and improved quality of life in children and adults with all types of VWD. The treatment reduced the frequency of bleeding episodes by lowering the mean total annualized bleeding rate compared to on-demand treatment.
A fast-dissolving insert containing TAF and EVG was found safe and effective in preventing HIV transmission through anal sex. The study delivered high levels of the drugs to rectal tissue and fluid, with potential protection for up to three days after use.
Researchers found dapivirine levels in breast milk to be very low, posing no safety concerns. The study supports the inclusion of breastfeeding populations in global guidelines for the use of the dapivirine vaginal ring for HIV prevention.
Researchers from Tokyo Medical and Dental University investigated the safety of anti-VEGF drug Aflibercept in a cell culture model exposed to HTLV-1. The study found that treatment did not increase pro-viral load or proliferation of RPE cells, suggesting potential for intraocular use.
The DELIVER study found that the vaginal dapivirine ring posed no safety concerns when used in the third trimester of pregnancy. The study enrolled women at different stages of gestation and reported similar pregnancy outcomes between those using the ring and a placebo.
A study of over 350 patients with small vessel stroke found that the medications were well-tolerated and safe, suggesting potential benefits in improving patient outcomes. The results indicate that cilostazol and isosorbide mononitrate may help reduce recurrent stroke, cognitive impairment, and improve quality of life.
Researchers found no significant evidence of harm in lowering blood pressure targets after endovascular treatment, but trends suggested marginal benefit and potential worsening of long-term disability. Clinicians should consider auto-regulation of blood pressure unless above 180 mm Hg.
A new neuroprotectant medication called ApTOLL has been shown to improve survival and reduce long-term disability among patients with stroke. The study found that ApTOLL, when used in conjunction with standard treatments, reduced death and brain damage, suggesting a promising new approach to treating stroke.
The study found that estimated national costs of self-injury mortality rose by 143% from $0.46 trillion to $1.12 trillion over a 20-year period, primarily driven by increases in opioid and alcohol-related deaths. West Virginia has the highest per capita cost at $6,534, with total suicide costs increasing 58% to $502.7 billion.
The study found that implementing the Shed-MEDS protocol before discharge to a post-acute care facility reduced patients' medication burden. The intervention also decreased exposure to potentially inappropriate medications, with effects persisting for at least 90 days.
A new study found that tailoring medication doses to a patient's DNA leads to a 30% reduction in serious side effects. The 'DNA medication pass' allows doctors and pharmacists to adjust prescriptions based on a patient's genetic profile, resulting in improved effectiveness and safety.
A new study found that medication administration errors can lead to negative emotions in healthcare professionals, including feelings of fear, disturbed mood, sadness, and guilt. Immediate reassurance and guidance from seniors and colleagues can help mitigate these effects.
A comprehensive review of antidepressant use in chronic pain found that some classes were effective in treating certain conditions, while others showed unclear or unknown benefits. Serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine demonstrated efficacy for various pain conditions.
Researchers found that while some antidepressants are effective for certain pain conditions, most are either ineffective or the evidence is inconclusive. A more nuanced approach is needed when prescribing antidepressants for pain, say experts.
Researchers at Saint Louis University found that COVID-19 vaccination does not interfere with cancer immunotherapy in previously vaccinated patients. The study supports recommending vaccination to patients with cancer, including those receiving systemic therapies.
As abortion restrictions take effect, acute care surgeons should prepare to treat complications such as infection, haemorrhage, and injury to the uterus, bowel, bladder, and circulatory system. Experts argue that providers have an ethical duty to protect patient privacy and not report complications to law enforcement.
Researchers developed a translational step forward in treating brain tumors using intraventricular immunovirotherapy, which has shown safety and efficacy in recent clinical trials. This approach uses oncolytic herpes simplex virus type-1 to target high-grade glioma with promising results.
Researchers seek to reduce medical errors among patients with limited English proficiency by implementing three different translation approaches. The goal is to compare the effectiveness of telephone interpreter-based and in-person interpreter-assisted communication in reducing errors.
Researchers have developed a novel portable and low-cost macroscopic mapping system for all-optical cardiac electrophysiology using optogenetics and machine vision cameras. The system can stimulate and image engineered networks of human heart cells, providing insights into cardiac wave function and stability.
Researchers found that letters successfully encouraged clinicians to check patients' prescribing records, leading to increased PMP search rates and persistent effects. The findings suggest a cost-effective evidence-based strategy for promoting safer prescribing practices through simple letter interventions.
A USC study found that notifying clinicians about fatal opioid overdoses through letters from medical examiners reduces opioid prescribing over the next three months. The study shows these notifications have a lasting impact, with a 7% reduction in prescriptions after one year.
The American College of Physicians recommends bisphosphonates as initial pharmacologic treatment to reduce fracture risk in osteoporosis patients. Long-term use may increase risks, so treatment duration should be limited to 5 years or less.
Research from University of Virginia Health System suggests antidepressants can heighten lifelong brain changes in babies, such as autism, when combined with infection or inflammation during pregnancy. SSRIs interact powerfully with the mother's body, causing harmful changes in the placenta and developing brain.
Research from the University of Ottawa finds that oral contraceptives' effects on brain and mood in women may be linked to age of onset and gut microbiome. The study suggests adolescence as a critical period for understanding OCs' impact, as it influences brain development and hormonal changes.
The American Society of Anesthesiologists' (ASA) new practice guidelines for monitoring and reversing neuromuscular blockade aim to reduce residual paralysis after general anesthesia. This can lead to decreased postoperative complications such as pneumonia, respiratory arrest, and reintubation.
A new hotline has shown promising results in preventing overdoses and saving lives by providing virtual supervision for people using substances alone. The National Overdose Response Service received over 2,100 calls from unique callers, with no reported deaths during a pilot period.
A new American Heart Association scientific statement highlights the potential benefits and risks of complementary and alternative therapies for heart failure. The statement advises healthcare professionals to discuss CAM use with patients, monitor medication interactions, and consider pharmacists' consultations.
A self-service vending machine filled with harm reduction supplies such as naloxone helped prevent overdoses and contributed to a decrease in Hamilton County's overdose deaths in 2021. Nearly 900 people used the machine since its installation, with nearly 16% of users reporting they had never used harm reduction services before.
A national US study found a 245% increase in child marijuana abuse and a decline in alcohol abuse over the past 20 years. The study tracked intentional misuse and abuse reported to the National Poison Data System from 2000 to 2020, revealing over 338,000 instances of child abuse or misuse.
A study suggests that abruptly stopping prescribed opioids for chronic pain increases the risk of overdose, particularly among individuals without opioid use disorder. However, tapering opioid therapy is associated with a decreased risk of overdose in those with opioid use disorder who have not received opioid agonist therapy.
A pilot study found that nearly half of patients treated with aflibercept could safely stop eye injections without vision loss, while only 17% of those on bevacizumab were able to do so. The findings suggest that matching patients with the right therapy may reduce the need for lifelong treatment.
Researchers found that buprenorphine use was associated with better outcomes for the baby, including lower risk of preterm birth, small size for gestational age, and low birth weight. The study suggests increasing access to buprenorphine treatment among pregnant individuals with opioid-use disorder.
A survey of primary care physicians revealed that those with beliefs about BZD potential harm were less likely to prescribe it. Clinicians with low concern about continuing BZDs for long-term treatment were more likely to prescribe the medication.